Literature DB >> 9830884

Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment.

D C Turk1, A Okifuji, J D Sinclair, T W Starz.   

Abstract

OBJECTIVES: To evaluate differential treatment responses among 3 empirically derived, psychosocial subgroups of patients with fibromyalgia syndrome to a standard interdisciplinary treatment program.
METHOD: Patients were classified into 1 of 3 psychosocial groups on the basis of their responses to the Multidimensional Pain Inventory. Forty-eight patients completed a 6 one-half-day outpatient treatment program consisting of medical, physical, occupational, and psychological therapies spaced over a period of 4 weeks (3 sessions the first week followed by 1 session per week for the next 3 consecutive weeks).
RESULTS: Statistically significant reductions were observed in pain, affective distress, perceived disability, and perceived inteference of pain in the patients characterized by poor coping and high level of pain ("dysfunctional" group). In contrast, individuals who were characterized by interpersonal difficulties ("interpersonally distressed" group) exhibited poor responses to the treatment. "Adaptive copers," the third group, revealed significant improvements in pain but due to low pretreatment levels of affective distress and disability showed little improvement on these outcomes.
CONCLUSIONS: The results provided support for the hypothesis that customizing treatment based on patients' psychosocial needs will lead to enhanced treatment efficacy. They also emphasize the importance of using appropriate outcome criteria, as low levels of problems at baseline are not likely to show significant changes following any treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9830884     DOI: 10.1002/art.1790110511

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  55 in total

Review 1.  [Recommendations for treatment of fibromyalgia : Where will we stand in 10 years?]

Authors:  K Thieme; D C Turk
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

2.  Is psychological distress intrinsic to fibromyalgia syndrome? Cross-sectional analysis in two clinical presentations.

Authors:  Monika Salgueiro; Zigor Aira; Itsaso Buesa; Juan Bilbao; Jon Jatsu Azkue
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

Review 3.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

4.  Fibromyalgia: revisiting the literature.

Authors:  Diane Forbes; Andrew Chalmers
Journal:  J Can Chiropr Assoc       Date:  2004-06

5.  [Multidisciplinary treatment rheumatoid arthritis. Statistical and clinical change in pain experience].

Authors:  U Klages
Journal:  Schmerz       Date:  2005-02       Impact factor: 1.107

6.  Interdisciplinary treatment of chronic pain.

Authors:  M A Gardea; R J Gatchel
Journal:  Curr Rev Pain       Date:  2000

7.  You get used to it, or do you: symptom length predicts less fibromyalgia physical impairment, but only for those with above-average self-efficacy.

Authors:  Charles Van Liew; Gabriel Leon; Mikayla Neese; Terry A Cronan
Journal:  Psychol Health Med       Date:  2018-09-30       Impact factor: 2.423

8.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

9.  Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?

Authors:  M L Verra; F Angst; R Brioschi; S Lehmann; F J Keefe; J Bart Staal; R A de Bie; A Aeschlimann
Journal:  Pain Res Manag       Date:  2009 Nov-Dec       Impact factor: 3.037

10.  Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study.

Authors:  Juliana Barcellos de Souza; Philippe Goffaux; Nancy Julien; Stephane Potvin; Jacques Charest; Serge Marchand
Journal:  Rheumatol Int       Date:  2008-09-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.